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This paper presents a characterisation of vaccinia virus (VV) gene B7R that was predicted to encode a polypeptide of 182
amino acids with an N-terminal signal peptide. In vitro transcription and translation analysis showed the B7R gene product
was a 21-kDa protein that, in the presence of microsomes, was processed into an 18-kDa mature form. The 18-kDa form
associated with the microsomal membranes and was within the lumen of the vesicle where it was inaccessible to exogenous
protease or an antibody raised against the B7R C terminus. Within VV-infected cells, the 18-kDa form of B7R was detected
late during infection in the endoplasmic reticulum where it colocalised with protein disulphide isomerase. The B7R protein
was detected neither in the culture supernatant nor associated with virus particles. A virus deletion mutant lacking the B7R
gene and a revertant virus were constructed. Compared to wild-type and revertant viruses, the deletion mutant replicated
normally in cell culture and had unaltered virulence in a murine intranasal model of infection. However, the deletion mutant
was attenuated in a murine intradermal model where it induced a smaller lesion than the control viruses. © 2000 Academic Press
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Poxviruses form a family of large, eukaryotic, dsDNA
viruses that replicate in the cytoplasm and encode their
own enzymes for transcription and DNA replication
(Moss, 1996; Traktman, 1996). The 192-kb genome of
vaccinia virus (VV) strain Copenhagen has been se-
quenced and encodes ;200 genes (Goebel et al., 1990).
The central portion of the genome contains genes that
mostly are essential for virus replication (Johnson et al.,
1993), while both termini contain nonessential genes
(Perkus et al., 1991) that may affect virus host range,
virulence, or the host response to infection (Buller and
Palumbo, 1991; Smith et al., 1997).
The B7R ORF is located near the right terminus of the
VV strain Copenhagen genome and is predicted to en-
code a protein containing 182 amino acids with a mo-
lecular weight of 21.3 kDa (Goebel et al., 1990). In VV
strain Western Reserve (WR), the ORF is conserved
(100% amino acid identity) and contains a hydrophobic
region near the N terminus that might represent a signal
sequence (Howard et al., 1991). This observation, to-
gether with the absence of any other potential hydropho-
bic transmembrane domain, suggested the B7R protein
might be secreted. The B7R ORF is conserved in VV
strain modified virus Ankara (ORF 175 shares 97% amino
acid identity with the B7R in VV Copenhagen and WR)
(Antoine et al., 1998) and also has counterparts in some
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65other orthopoxviruses. It shares 97.8% amino acid iden-
tity with the B6R ORF of cowpox virus (Shchelkunov et al.,
1998) but is broken in variola virus strains Bangladesh-
1975 and India-1967 (Shchelkunov et al., 1995). There are
also related ORFs in the leporipoxviruses: the VV WR B7R
protein shares 21.4% amino acid identity over 126 amino
acids with the C-terminal domain of the T2 protein of
Shope fibroma virus (Howard et al., 1991). The function of
the C-terminal domain of the closely related myxoma
virus (M)-T2 protein is unknown, but it is postulated to
have a role in intracellular trafficking of the protein
(Schreiber and McFadden, 1996). The N-terminal, cys-
teine-rich domains of the M-T2 protein bind TNF-a and
inhibit apoptosis of infected lymphocytes (Schreiber et
al., 1997).
Membrane and soluble proteins leave the ER not only
by bulk flow, the default pathway (Wieland et al., 1987)
but, in certain cases, by selective interactions of the
proteins (via receptors, in the case of soluble proteins)
with the ER-derived coat protein (COPII)-covered vesi-
cles (Schimmoller et al., 1995). Further sorting occurs by
etrieval of ER proteins from post-ER compartments (Pel-
am, 1988) or by active retention of proteins in the ER
Duvet et al., 1998). Proteins are retained in the ER
ecause either they contain an ER retention/retrieval
equence or they bind to other proteins that have an ER
etention/retrieval sequence (Gething et al., 1986; Sato et
l., 1996).
The B7R gene was chosen for study because it is
ocated in a region of the VV genome that is rich in
mmunomodulators, it encodes a protein that may be
0042-6822/00 $35.00
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66 PRICE ET AL.secreted, and has amino acid similarity to the leporipox-
virus T2 proteins that have immunomodulatory functions.
Here we have characterised the VV B7R protein and
show that it is resident in the endoplasmic reticulum (ER)
and does not affect virus growth properties in vitro.
However, loss of the gene attenuates the virus in a
murine intradermal model.
RESULTS
The B7R gene encodes an 18-kDa protein expressed
late during infection
To help identify and characterise the function of the
B7R gene product, a virus deletion mutant lacking 60% of
the ORF (vDB7R), a plaque purified wild-type virus
(vWTB7R), and a revertant virus in which the B7R gene
was reinserted into vDB7R (vB7R-rev) were constructed
as described under Materials and Methods. Southern
blotting and PCR analysis of these recombinant virus
genomes confirmed the genome structures were as pre-
dicted (data not shown).
The B7R nucleotide sequence contains an early tran-
scription termination signal (TTTTTNT) (Yuen and Moss,
1987) partway through the ORF and a potential late tran-
scriptional start site (TAAATG) (Rosel et al., 1986; Weir
and Moss, 1987; Davison and Moss, 1989) at the begin-
ning of the ORF, suggesting that the gene might be
transcribed late during infection. To test this experimen-
tally, RNA was extracted from infected cells at different
times after infection and was examined by Northern
blotting with an anti-sense, B7R-specific, RNA probe that
had been generated in vitro (Materials and Methods)
(Fig. 1A). This probe detected RNAs of heterogeneous
length from 4 h p.i. (lanes 2–4), but not from mock-
infected cells (lane 5). Because VV late mRNAs are
heterogeneous in length due to a failure to terminate at
specific sites (Moss, 1996), the late RNAs could repre-
sent transcripts generated from promoters of either up-
stream genes or from the B7R gene itself. No B7R mRNA
was detected from cells infected in the presence of
either cycloheximide (an inhibitor of protein synthesis)
(lane 6) or araC (an inhibitor of DNA replication) (lane 7),
indicating that the B7R gene is transcribed only late
during infection. The probe also detected RNA from
vDB7R-infected cells, but at lower levels (lane 8), pre-
sumably because of the deletion of the majority of the
B7R ORF to which the probe would hybridise.
The expression of the B7R protein in virus-infected
cells was examined using a rabbit polyclonal antiserum
raised to the hydrophilic domain of B7R (amino acids
20–182) that was expressed as a fusion protein in Esch-
erichia coli. The B7R-specific Ig was affinity purified as
described under Materials and Methods and called
a-B7R-1 Ig. Cellular extracts were prepared at different
2times p.i. from TK 143B cells that had been either mock-
infected (Fig. 1B, lane 1) or infected with vWTB7R in the
g
cpresence (lane 4) or absence (lanes 2 and 3) of araC and
were immunoblotted with a-B7R-1 (Fig. 1B, top). A protein
f 18 kDa was detected only at 24 h p.i. in the absence
f araC (lane 3). A rabbit polyclonal antiserum against
he B1R protein (a-B1R antibody) (Banham and Smith,
992) was used on parallel blots to show that virus-
pecific protein was present in lanes 2–4 (Fig. 1B, bot-
om). These data show that B7R encodes an 18-kDa
rotein that is expressed late during VV infection, in
greement with the transcriptional analysis above.
he B7R protein is unstable in the presence
f glycosylation inhibitors
To determine whether the B7R protein is modified by
lycosylation, cells were infected in the presence or
bsence of either tunicamycin, an inhibitor of N-linked
FIG. 1. (A) Northern blot analysis of B7R mRNA. RNA from mock-
infected cells (M) or cells infected either with vDB7R (D7) or VV strain
WR for the indicated times (top row, h) in the presence or absence of
100 mg/ml cycloheximide (cyclo) or 40 mg/ml araC, was resolved on an
1.2% agarose gel and transferred to a nylon filter. The filter was hybrid-
ized with an antisense, ssRNA probe specific for the B7R ORF (Mate-
rials and Methods). Positions of size markers are shown in kb. (B)
Immunoblot analysis of the B7R protein synthesised in the presence or
absence of araC. Monolayers of TK2143B cells were mock-infected
(lane 1) or infected with vWTB7R at 10 PFU/cell and harvested at 4 h p.i.
(lane 2) or 24 h p.i. in the absence (lane 3) or presence (lane 4) of 40
mg/ml araC. Samples were analysed by immunoblotting with a-B7R-1
Ig or with a-B1R antibody as described under Materials and Methods.
Positions of molecular weight markers are indicated in kDa.lycosylation, or monensin, an inhibitor of O-linked gly-
osylation and vesicular transport (Fig. 2). Extracts from
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67VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCEmock or vWTB7R-infected cells were prepared at 24 h p.i.
and analysed by immunoblotting with a-B7R-1 Ig (Fig. 2,
op). Parallel blots were also probed with a MAb AB1.1
gainst the VV D8L protein (Parkinson and Smith, 1994)
middle) and a rabbit polyclonal antiserum against the
5R protein (Engelstad et al., 1992) (bottom). The B7R
rotein was not detected in the presence of these gly-
osylation inhibitors, whereas the level of D8L protein
as unaltered under these conditions. The B5R protein
s modified by N-linked glycosylation so that in the pres-
nce of tunicamycin its size decreases from 42 to 40
Da. It is unlikely the B7R protein is glycosylated be-
ause pulse–chase analysis and immunoprecipitation of
7R showed no increase in size of the protein during the
hase period (data not shown), and there is no N-linked
lycosylation motif (NXS/T) in the ORF (Howard et al.,
991). This result might suggest that the stability of B7R
n the cell is dependent on the glycosylation of another
rotein.
he B7R protein is a nonstructural, intracellular
rotein
The presence of the B7R protein in infected cells,
ulture supernatants, and virions was examined by im-
unoblotting. Cells were mock-infected or infected with
WTB7R, vDB7R, or vB7R-rev, and both cells and super-
FIG. 2. Immunoblot analysis of the B7R protein in the presence or
absence of glycosylation inhibitors. Monolayers of TK2143B cells were
ock-infected (lane 1) or infected with vWTB7R at 10 PFU/cell and
ncubated for 24 h in the presence of no drug (lane 2), 1 mM monensin
(Mon, lane 3), 10 mg/ml tunicamycin (Tun, lane 4), or tunicamycin and
monensin (lane 5). Cell extracts were resolved by SDS–PAGE, trans-
ferred to nitrocellulose and reacted with the a-B7R-1 Ig (top) and bound
g was detected as described under Materials and Methods. Parallel
lots were probed with MAb AB1.1 (anti-D8L) (middle) and rabbit poly-
lonal a-B5R antibody (bottom). Positions of molecular weight markers
are indicated in kDa.atants were harvested at 24 h p.i. (Fig. 3A). The super-
atant was centrifuged to remove any cellular debris and birus particles, and proteins in the clarified supernatant
ere concentrated by TCA precipitation. Cellular and
upernatant samples were then analysed by immuno-
lotting using a-B7R-1 Ig. Blots were washed and then
reprobed with a rabbit polyclonal a-B5R antibody (En-
gelstad et al., 1992) that recognises the cellular 42-kDa
and secreted 35-kDa B5R proteins. The a-B7R-1 Ig de-
tected an 18-kDa protein in fractions of cells infected
with either vWTB7R or vB7R-rev but not vDB7R. The B7R
protein was not evident in the supernatant of infected
cells in contrast to the 35-kDa B5R protein that was
detected easily in the supernatant.
To determine whether the B7R protein was present in
FIG. 3. Immunoblot analysis of B7R protein. (A) B7R is an intracellular
protein. BS-C-1 cells were mock-infected (lanes 1 and 5) or infected
with vWTB7R (lanes 2 and 6), vDB7R (lanes 3 and 7), or vB7R-rev (lanes
4 and 8) at 2 PFU/ml. Cellular (lanes 1–4) and supernatant (lanes 5–8)
fractions were harvested and processed as described under Materials
and Methods. The blot was reacted with a-B7R-1 Ig (top), and bound Ig
as detected as described under Materials and Methods. The blot was
ashed and reprobed with the rabbit a-B5R antibody (bottom). Posi-
tions of molecular weight markers are indicated in kDa. The arrows
point to the B7R protein (top) and the cellular and secreted forms of B5R
(bottom). (B and C) The B7R protein is not present in VV particles.
Purified IMV (B) or EEV (C) proteins of vWTB7R (lane 3), vDB7R (lane 4),
or vB7R-rev (lane 5) and extracts from vWTB7R-infected cells (lane 1)
harvested at 24 h p.i., were immunoblotted with a-B7R-1 Ig (top). The
lots were reprobed with the mouse a-D8L MAb AB1.1 (B, bottom) or
with both mouse a-D8L MAb AB1.1 and rabbit a-B5R antibody (C,
ottom). Positions of molecular weight markers are indicated in kDa.
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68 PRICE ET AL.virus particles, vWTB7R, vDB7R, and vB7R-rev were
rown in RK13 cells, and EEV was purified from the
culture supernatant by sucrose density gradient centrif-
ugation. IMV was purified from cytoplasmic extracts in
parallel. Solubilised virus proteins were then analysed by
immunoblotting with a-B7R-1 Ig (Figs. 3B and 3C). This
antibody did not detect the B7R protein in either IMV (Fig.
3B) or EEV (Fig. 3C) samples, although it detected the
B7R protein in infected cell extracts. As a control, the
blots were washed and reprobed with MAb AB1.1 (anti-
D8L) to confirm equivalent protein loading. For the EEV
samples, the a-B5R antibody was also included to con-
irm the presence of EEV protein in the samples. Evi-
ently, B7R is not incorporated into virus particles.
he B7R protein is resident in the endoplasmic
eticulum
The intracellular location of B7R was investigated by
mmunofluorescence. The a-B7R-1 Ig did not give a sig-
al in immunofluorescence, and therefore a new poly-
lonal rabbit antiserum (a-B7R-2) was raised against a
synthetic peptide representing the C-terminal 10 amino
acids of the B7R protein (Materials and Methods). In
cells infected with vWTB7R, a-B7R-2 showed a reticular
staining pattern (Figs. 4D and 4G) that was absent in
vDB7R-infected cells (Fig. 4A). Staining the same cells
with a mouse MAb 1D3 against protein disulphide
isomerase (PDI) (Vaux et al., 1990), showed a similar
staining pattern (Figs. 4B, 4E, and 4H). B7R and PDI were
shown to be coincident by merging the two images (Figs.
4F and 4I), confirming that the B7R protein is resident in
the ER.
Additional evidence that B7R is an ER protein was
obtained by immunohistochemistry. BS-C-1 cells were
infected with either vWTB7R or vDB7R and at 18 h p.i.
were fixed and permeabilised and then incubated with
a-B7R-2 antibody. Bound antibody was detected using an
HRP-conjugated secondary antibody and DAB staining
(Materials and Methods). Sections of cells (80- to 150-nm
thick) were then analysed by electron microscopy (Fig.
5). Cells infected with vDB7R showed little staining (Figs.
5B and 5D), whereas the vWTB7R-infected cells showed
a reticular and nuclear envelope staining pattern (Figs.
5A, 5C, and 5E). The virus factories (V), Golgi (G), and
plasma membrane (PM) were unstained (Figs. 5A, 5C,
5E, and 5F), whereas the nuclear envelope (Fig. 5C) and
fenestrated ER (Fig. 5E) showed staining in vWTB7R-
infected cells. The inset in Fig. 5F illustrates the un-
stained Golgi at a higher magnification.
These data, taken together with the lack of secretion of
B7R from infected cells, its absence from virions, and its
colocalisation with PDI, support the conclusion that B7R
is resident in the ER.
B
sAnalyses of the B7R protein synthesised in vitro
To determine whether the B7R protein was associated
with membranes and, if so, to examine the membrane
topology, the B7R protein was synthesised in vitro by
transcription and translation in the presence or absence
of microsomal membranes (Fig. 6). In the absence of
microsomes, a 21-kDa protein was produced (Fig. 6A,
lane 4) and this protein remained in the soluble fraction
(S) after centrifugation (Fig. 6A, lane 6). The protein was
not observed when translation was performed in the
absence of a B7R-specific transcript (data not shown).
When canine pancreatic microsomes were included in
the translation reaction, an 18-kDa protein was also
produced (Fig. 6A, lane 1) that sedimented with the
microsomes into the pellet (P) during centrifugation (Fig.
6A, lane 2). The size of this protein is consistent with its
formation by proteolytic cleavage of the 21-kDa form to
remove the signal peptide. The 21-kDa protein is also
associated partly with the membrane fraction (Fig. 6A,
lanes 2 and 3), suggesting that the microsomes do not
process all the 21-kDa protein quickly. In control trans-
lation reactions, yeast a-factor (Promega) increased in
size from 19-kDa in the absence of microsomes to 30
kDa in the presence of microsomes. In the latter case,
the protein sedimented with microsomes during centrif-
ugation consistent with its presence in the lumen of the
vesicle (data not shown).
To assess whether the 18- or 21-kDa form of B7R
produced in vitro comigrated with the form identified in
virus-infected cells, both reticulocyte and cellular lysates
were subjected to immunoprecipitation with a-B7R-2 an-
ibody followed by SDS–PAGE (Fig. 6B). The 18-kDa B7R
rotein that was found in virus-infected cells (Fig. 6B,
ane 1) comigrated with the 18-kDa form of B7R produced
n vitro in the presence of microsomes (Fig. 6B, lane 2)
ather than the 21-kDa protein formed in the absence of
icrosomes (Fig. 6B, lane 3).
The association of the B7R protein with microsomes
nd its processing could have been either cotransla-
ional or posttranslational. To investigate this, the B7R
ranscript was translated in the presence or absence of
icrosomes, and then microsomes were added to the
atter sample in the presence of cycloheximide to inhibit
ew protein synthesis (Fig. 6C). Processing of 21-kDa
rotein to the 18-kDa form occurred only when the mi-
rosomes were present during translation of the protein
Fig. 6C, lane 1) and not when the microsomes were
dded to preformed B7R protein (Fig. 6C, lane 2).
The B7R protein sedimented with microsomes during
entrifugation, and this could have been because it was
n integral membrane protein, membrane-associated
rotein, or lumenal protein. To examine how B7R was
ssociated with microsomes, microsomes containing the
7R protein were extracted with either Triton X-100 or
odium carbonate pH 11 and then separated into soluble
G
and (G
69VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCE(S) and pellet (P) fractions by centrifugation (Fig. 6D).
Sodium carbonate punctures microsomal membranes
and solubilises membrane-associated proteins, whereas
integral membrane proteins remain with the membrane.
Triton X-100 disrupts and solubilises both integral mem-
brane and membrane-associated proteins. As controls,
an integral membrane protein, VV A38L (Parkinson et al.,
1995), and a lumenal protein, yeast a-factor, were trans-
FIG. 4. Immunofluorescence of infected cells showing the ER localis
vWTB7R (D-I) or vDB7R (A–C) for 12 h. Cells were then fixed, permeab
) and mouse a-PDI MAb 1D3 (B, E, and H), and bound Ig was detec
under Materials and Methods. Merged images of (A and B), (D and E),
(A–F), 3963 (G–I).lated and analysed in parallel. Both a-factor and A38L
were solubilised by Triton X-100 (Fig. 6D, lane 5),whereas a-factor was solubilised by sodium carbonate
and A38L was not (Fig. 6D, lanes 2 and 3). In comparison,
the B7R protein was nearly all solubilised by Triton X-100
(Fig. 6D, lane 5) but was distributed equally between
soluble and pellet fractions after sodium carbonate ex-
traction (Fig. 6D, lanes 2 and 3). The behaviour of the B7R
protein is characteristic of neither an integral membrane
nor a soluble protein but of a membrane-associated
f the B7R protein. BS-C-1 cells were infected at 2 PFU/cell with either
nd incubated with both polyclonal rabbit a-B7R-2 antibody (A, D, and
h FITC- or rhodamine-conjugated secondary antibodies as described
and H) are shown in (C), (F), and (I), respectively. Magnification, 3385ation o
ilised, a
ted witprotein.
The membrane topology of B7R was examined by
70 PRICE ET AL.
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71VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCEadding trypsin to microsomes in the presence or ab-
sence of Triton X-100 (Fig. 6E). The B7R protein and yeast
a-factor were protected from digestion by trypsin (Fig.
6E, lane 4), but when Triton X-100 was added to disrupt
the membrane, both proteins were digested (Fig. 6E,
lane 5), showing that each is located on the lumenal side
of the membrane. This topology was confirmed (Fig. 6F)
by using the a-B7R-2 antibody, raised against the C
terminus of B7R, to immunoprecipitate the translation
products in the presence or absence of Triton X-100. In
the absence of Triton X-100, the a-B7R-2 antibody was
unable to immunoprecipitate the B7R protein (Fig. 6F,
lane 2), but in the presence of Triton X-100 to disrupt the
membrane, both the 18- and 21-kDa B7R gene products
were immunoprecipitated (Fig. 6F, lane 1). These data
indicate that B7R is located on the lumenal side of the
microsomal membrane and that proteolysis does not
occur at the C terminus.
Loss of the B7R gene has no effect on virus
replication in vitro
The isolation of vDB7R showed that the B7R gene was
nonessential for replication of VV strain WR in vitro, as
predicted by its location near the right terminus of the
genome (Johnson et al., 1993). To determine whether loss
of B7R affects virus replication in cell culture, the forma-
tion of infectious virus was measured after infection of
BS-C-1 cells at 0.01 PFU/cell (Fig. 7). Under these con-
ditions, there was no difference between the replication
of vWTB7R, vDB7R, or vB7R-rev for either cell-associated
(Fig. 7B) or extracellular virus (Fig. 7A). The three viruses
also shared similar growth characteristics after infection
of BS-C-1, Jurkat E6.1, and THP-1 cells at 10 PFU/cell
(data not shown). The size and morphology of plaques
formed by vDB7R on BS-C-1 cells was unaltered com-
pared to control viruses (Fig. 7C).
Loss of the B7R gene attenuates virus virulence
in a murine intradermal model of infection
Although the B7R ORF is nonessential for the replica-
tion of VV in vitro, the gene product might contribute to
virus virulence in vivo. This was assessed first in a
murine intranasal model of infection, but no difference in
the weight loss or mortalities of animals infected with
vDB7R compared to vWTB7R or vB7R-rev was observed
(data not shown). The virulence of vDB7R was then
assessed in a murine intradermal model. In this model,
FIG. 5. Pre-embedding immunocytochemistry of infected cells show
PFU/cell with either vWTB7R (A, C, E, and F) or vDB7R (B and D) for 18 h
ntibody, followed by HRP-conjugated goat a-rabbit Ig and then DAB. F
Materials and Methods. The length of the scale bars represents 4000
inset scale bar is 100 nm). N, nucleus; NE, nuclear envelope; V, virus factory;
and G, Golgi. The black arrow in (F) points to the area of the Golgi magnifiedinoculation of 104–106 PFU of VV strain WR leads to a
localised and limited infection in the ear pinnae with little
infectious virus disseminating to local lymph nodes or
other organs (Tscharke and Smith, 1999). The size of the
lesion on the ear pinnae can be measured easily. Mouse
ears were injected intradermally with 5 3 104 PFU/ear of
WTB7R, vDB7R, and vB7R-rev, and the diameter of re-
ulting lesions was measured daily for groups of at least
ix mice. No animal exhibited signs of systemic infection,
ut mice infected with vDB7R had smaller lesions from 7
ays p.i. compared with mice inoculated with vWTB7R or
B7R-rev (Fig. 8A). The Mann–Whitney U-test showed a
ignificant difference (P , 0.05) between the mean val-
es for the vDB7R-infected group compared to each
ther group on days 7–11. In addition, the unpaired Stu-
ent’s t test showed a significant difference (P , 0.009)
hen pooled sample means across days 7–15 were
ompared. The maximal lesion size was reached at 10
ays p.i. in the vDB7R-infected mice and a day later in
ice inoculated with vWTB7R or vB7R-rev. The titer of
nfectious virus in ears at various times postinfection
as determined by plaque assay of ground tissue sam-
les from groups of three mice at each time point (Fig.
B). For each virus, the titer reached a peak of ;5 3 106
PFU/ear at 5 days p.i. and then declined. There was no
significant difference in virus titer after infection with the
different viruses, at least at the times measured and with
these group sizes.
DISCUSSION
This paper provides a characterisation of the B7R
gene of VV strain WR. Data presented show that the gene
is transcribed late during infection and encodes an 18-
kDa protein that is not present in virus particles nor the
supernatant of infected cells but is located within the ER
of infected cells. In vitro translation in the presence of
microsomal membranes showed that B7R is present
within the vesicle as a membrane-associated protein. A
virus mutant lacking the majority of the B7R ORF showed
normal replication in cell culture but was attenuated in a
mouse dermal model of infection.
Expression of the B7R protein by in vitro transcription
and translation showed that the protein was synthesised
as a 21-kDa primary translation product, which, in the
presence of microsomal membranes, was processed
into an 18-kDa form that comigrated with the B7R
polypeptide found in VV-infected cells. This reduction in
e ER localisation of the B7R protein. BS-C-1 cells were infected at 5
were then fixed, permeabilised, and incubated with the rabbit a-B7R-2
the cells were processed for electron microscopy as described under
(A and B), 2000 nm in (C and D), 800 nm in (E), and 400 nm in (F; theing th
. Cells
inally,
nm inER, endoplasmic reticulum; PM, plasma membrane; M, mitochondria;
in the inset.
p
(
p
72 PRICE ET AL.FIG. 6. In vitro translation of the B7R protein. (A) B7R protein was translated in vitro in the presence (lanes 1–3) or absence (lanes 4–6) of canine
ancreatic microsomes. Soluble and membrane components of the total (T) in vitro translation reaction were separated into supernatant (S) and pellet
P) fractions by centrifugation. (B) Immunoprecipitation of the B7R protein from the in vitro translation reaction and from virus-infected cells. 35S-met-
and 35S-cys-labeled lysates from cells infected with vWTB7R (lane 1) or the B7R protein translated in vitro in the presence (1) or absence (2) of
microsomal membranes, were immunoprecipitated with the a-B7R-2 antibody. (C) Signal sequence cleavage occurs as a cotranslational event. B7R
rotein was translated in vitro in the presence (1) or absence (2) of microsomal membranes for 1 h. In the presence of 100 mg/ml cycloheximide,
microsomal membranes were then added to the sample that hitherto lacked membranes (2/1) and incubation was continued for a further 1 h. The
proteins were then immunoprecipitated with the a-B7R-2 antibody. (D) Detergent and sodium carbonate (Na2CO3) extraction of the B7R protein. Yeast
a-factor (middle) and VV proteins A38L (top) and B7R (bottom) were translated in vitro in the presence of microsomal membranes. Membranes from
each translation reaction were then harvested by centrifugation (T) (lane 1). In each case, the membrane pellet was divided into two, and one half
was treated with 0.1 M Na2CO3 pH 11(lanes 2–4) and the other with 0.1% Triton X-100 (lanes 5–7). The samples were then floated over a sucrose
cushion and centrifuged to separate the soluble (S) fraction (lanes 2 and 5) from the insoluble (P) fraction (lanes 3 and 6). The sucrose cushion (C)
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73VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCEsize is likely to result from cleavage of the hydrophobic
N-terminal signal peptide sequence because both the
18- and 21-kDa forms were recognised by an antibody
directed against the C-terminal 10 amino acids. The
18-kDa form was shown to be present within the lumen
of the vesicles because it was inaccessible to digestion
by exogenous proteinase or recognition by specific an-
tibody unless the membrane was disrupted by addition
of detergent. The protein showed properties that were
characteristic of a membrane-associated protein rather
than an integral membrane protein. This suggests that
the association of the B7R protein with membranes
might be either direct, or via interaction with another
(nonvirus) protein. The latter possibility is supported by
was also collected and analysed. (E) Trypsin treatment of membrane-a
n vitro in the presence of microsomal membranes. The total fraction (
f either trypsin or Triton X-100 (lane 1), the second was incubated with
-100 and trypsin that had been inactivated by pre-treatment with trypsin
embranes, were separated into supernatant (S) (lane 2) and pellet (P
ne of which was incubated in the absence of either trypsin or Triton X
), and a third was incubated with both trypsin and Triton X-100 (lane 5
he B7R protein was translated in vitro in the presence of microsomes
FIG. 7. Growth of vDB7R in cell culture. (A and B) BS-C-1 cells were
or vB7R-rev (closed triangles). Samples of the culture supernatant and
by plaque assay on BS-C-1 cells. The data shown are the means 6 SE f
infected with vWTB7R, vDB7R, and vB7R-rev and overlaid with DMEM c
for 2 days prior to staining with 0.1% crystal violet in 15% ethanol.lane 2) of Triton X-100. Immunoprecipitation was performed using the a-B7R
resolved by SDS–PAGE and autoradiographs were prepared. The positions othe observation that, although the B7R protein does not
have any sites for addition of N-linked carbohydrate, in
the presence of tunicamycin it was unstable and was not
detected in infected cells by immunoblotting. Thus in
infected cells, the B7R protein might interact with a
cellular or virus glycoprotein that is unstable in the ab-
sence of N-linked carbohydrate.
The B7R protein synthesised in virus-infected cells
was characterised with the aid of two anti-B7R antibod-
ies. The first was raised against a GST-B7R fusion pro-
tein, and after affinity purification of the B7R-specific Ig,
this reagent was suitable for immunoblotting analyses.
These analyses showed that the protein was an intra-
cellular, nonstructural protein of 18-kDa that was ex-
ted B7R protein. Yeast a-factor (bottom) and B7R (top) were translated
divided into three parts, one of which was incubated in the absence
ypsin and Triton X-100 (lane 6), and the third was incubated with Triton
or (lane 7). Control translation reactions, in the presence of microsomal
3–5) by centrifugation. The pellet was divided into three equal parts,
ne 3), the second was incubated with trypsin but not Triton X-100 (lane
R associated with microsomes is not accessible to a-B7R-2 antibody.
e sample was incubated in the presence (lanes 1 and 3) or absence
d at 0.01 PFU/cell with vWTB7R (closed boxes), vDB7R (open circles),
as removed at different times p.i. and their virus infectivity was titrated
duplicate samples. (C) Plaque phenotype of vDB7R. BS-C-1 cells were
edium supplemented with 2.5% FBS and 1.5% carboxymethyl cellulosessocia
T) was
both tr
inhibit
) (lanes
-100 (la
). (F) B7
and thinfecte
cells w
rom the-2 antibody (lanes 1 and 2) or no antibody (lane 3). All samples were
f molecular weight markers are indicated.
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74 PRICE ET AL.pressed by all 16 VV strains tested and by cowpox virus
strains Brighton Red and elephantpox but not camelpox
virus (data not shown). Published nucleotide sequence
data show that the ORF is disrupted in variola major
viruses (Shchelkunov et al., 1995). Nonetheless, the con-
servation in all VV strains and in cowpox virus and the
presence of related ORFs in leporipoxviruses suggests
an important function for the protein.
FIG. 8. Virulence of vDB7R in mice. Lesion diameter (A) and virus titer
B) in groups of female BALB/c mice injected intradermally in the left
ar pinna with 5 3 104 PFU of vWTB7R (closed boxes), vDB7R (open
circles), or vB7R-rev (closed triangles). (A) The data points represent
the means 6 SE from groups of 12 mice up to day 8, 9 mice up to day
11, and 6 mice thereafter. The horizontal bar represents the comparison
of pooled sample means between the vDB7R group of mice and the
vWTB7R or vB7R-rev group across days 7–15 (unpaired Student’s t test,
P , 0.009). The stars represent days on which a comparison of sample
means of vDB7R vs vWTB7R or vB7R-rev showed significant differ-
ences (Mann–Whitney U test, P , 0.05). (B) On the indicated days after
infection, three animals infected with each virus were killed, and the
titer of infectious virus in the ear was determined by plaque assay on
duplicate BS-C-1 cells. Virus titers are expressed as PFU/ear. The bars
represent the means 6 SE of the virus titers.The second antibody was raised against a 10-amino-
acid synthetic peptide from the C terminus of the protein
c
mand was used for immunoprecipitation, immunofluores-
cence, and immunocytochemistry. Immunofluorescence
showed that the B7R protein had a reticular distribution
and colocalised with PDI in the ER. Immunocytochemis-
try confirmed the presence of B7R in the ER and revealed
that it was absent from virus particles, virus factories, the
Golgi complex, and plasma membrane.
Proteins are retained in the ER because they contain
an ER retention or retrieval sequence or they bind to
other proteins that contain these signals (Gething et al.,
1986; Sato et al., 1996). Several signals cause proteins to
accumulate in the ER: (i) KDEL, or variants of this, at the
C -terminus of soluble proteins (Munro and Pelham,
1987; Andres et al., 1990); (ii) RR near the cytoplasmic N
terminus of type 2 membrane proteins (Schutze et al.,
1994); (iii) K at position 23 and 24 or 25 of the C
erminus of type 1 membrane proteins (Jackson et al.,
990); (iv) transmembrane domains that rely on the pro-
ein sequence for retrieval (Sato et al., 1996; Rayner and
elham, 1997); and lastly (v) the transmembrane domain
f hepatitis C virus E1 and E2 proteins is responsible for
etention in the ER without recycling through the Golgi
Duvet et al., 1998).
The mechanism by which B7R is retained in the ER is
nknown. Although the N terminus contains a KK motif
nd a hydrophobic sequence, these are likely to be
emoved by proteolytic cleavage, and the protein does
ot behave as an integral membrane protein. There is a
NNEL (a modification of KDEL) motif at amino acid
ositions 49–52, but this sequence is not known to retain
roteins in the ER. So the retention of B7R in the ER
ight be due to either an unknown retention signal or via
he interaction with another protein(s). The former pos-
ibility can be assessed by a mutational analysis of B7R.
To address the role of B7R in virus infection, a recom-
inant virus lacking 60% of the ORF was constructed and
ompared with wild-type and revertant viruses. The iso-
ation of the deletion mutant indicated that the B7R gene
as nonessential for virus replication in cell culture and
nalyses of the growth properties and plaque phenotype
howed no differences from wild type. However, in a
urine intradermal model, the B7R protein affected the
utcome of infection and the deletion mutant induced
maller lesions than control viruses. The mechanism by
hich an intracellular protein resident in the ER affects
irus virulence in vivo, without affecting virus replication
er se, is unknown and interesting. One possibility is that
he interaction of B7R with another protein prevents the
ecretion or cell surface expression of protein(s) impor-
ant for the immune response to infection. Alternatively,
he B7R protein might affect apoptosis of infected cells.
n the leporipoxviruses, there is a precedent for an ER
rotein playing a role in pathogenesis where the T4
rotein of myxoma virus inhibits apoptosis of infected
ells (Barry et al., 1997). However, preliminary experi-
ents comparing the VV B7R deletion mutant with wild-
s
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75VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCEtype and revertant viruses found no alteration in apopto-
sis in Jurkat cells (data not shown).
In summary, the B7R gene encodes an 18-kDa protein
that is retained in the ER by either a novel retention
signal or by interaction with another ER-resident protein.
The loss of the B7R gene results in virus attenuation in
vivo by an unknown mechanism.
MATERIALS AND METHODS
Cells and viruses
Monkey kidney BS-C-1 and CV-1 cells, rabbit kidney
(RK)13 cells, human osteosarcoma TK
2143B cells and
HeLa D980R cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) (Gibco). VV strain WR and recombi-
nants derived from it were grown in RK13 cells. Working
stocks of virus were prepared by sedimentation of cyto-
plasmic extracts of cells through a sucrose cushion as
described (Mackett et al., 1985). Virus infectivity was
titrated by plaque assay on BS-C-1 cells (Mackett et al.,
1985). Purified IMV and EEV were prepared from RK13
cells 2 days p.i. at 0.1 PFU/cell as described (Parkinson
and Smith, 1994).
Plasmid constructions
Plasmid pNP1was used to express a glutathione–S-
transferase (GST)-B7R fusion protein in E. coli. The B7R
ORF, lacking the N-terminal hydrophobic sequence (20
amino acids), was amplified by polymerase chain reac-
tion (PCR) from pSTH1 DNA (Howard et al., 1991) to
produce a fragment of 506 bp. The forward oligonucleo-
tide 59-TATCGGATCCAATAATGAGTACACTCCG-39 con-
tains a BamHI site (underlined) and starts 60 bp down-
tream of the B7R initiation codon, whereas the reverse
ligonucleotide 59-GAGCGAATTCTTAAAAATCATATTT-
TGA-39 has an EcoRI site (underlined) and the termina-
tion codon (complement of) is shown in bold. The PCR
fragment was digested with BamHI and EcoRI and then
was ligated into the BamHI- and EcoRI-cut pGEX-2T
expression vector (Smith and Johnson, 1988) to form
pNP1. The nucleotide sequence of the cloned PCR frag-
ment was verified by DNA sequencing.
Plasmid pNP3 was used as the template for in vitro
transcription and also to create the single-stranded (ss)
RNA probe for use in Northern blotting. Plasmid pSTH1,
containing the full B7R ORF, was digested with SpeI and
then made blunt-ended by treatment with Klenow en-
zyme in the presence of dNTPs. A 685-bp DNA fragment
containing the B7R ORF was ligated into the plasmid
pGEM-4Z (Promega) that had been digested with SmaI
and dephosphorylated with calf intestinal alkaline phos-
phatase (CIP), to form pNP3. The orientation of the B7R
gene in the vector was established by digestion with PstI
and agarose gel electrophoresis. This showed the B7R
ORF was under the control of the T7 promoter.Plasmid pNP5 containing the full B7R ORF and flank-
ing sequences was constructed to make the B7R rever-
tant virus by transient dominant selection (TDS) (Falkner
and Moss, 1990). An EcoRV 1564-bp fragment, containing
the entire B7R gene and 535 bp upstream and 480 bp
downstream, was excised from pSTH1. This was cloned
into pSJH7 (Hughes et al., 1991), which had been di-
gested with PstI, made blunt-ended by treatment with T4
DNA polymerase, and dephosphorylated with CIP, to
form plasmid pNP5.
Plasmid pNP6 was used to make the B7R deletion
virus by TDS. Plasmid pNP5 was digested with BstBI and
PstI to excise a 344-bp fragment from the B7R gene
(nucleotides 56–400, 60% of the ORF). The remaining
plasmid was made blunt-ended by treatment with T4
DNA polymerase in the presence of dNTPs and religated
to form plasmid pNP6.
Construction of a B7R deletion mutant and revertant
virus
A virus deletion mutant lacking 60% of the B7R ORF
was constructed by TDS (Falkner and Moss, 1990) using
the Ecogpt gene as the transient selectable marker
(Boyle and Coupar, 1988; Falkner and Moss, 1988) as
described (Kettle et al., 1995). CV-1 cells were infected
with VV strain WR at 0.05 PFU/cell and transfected with
pNP6. MPA-resistant plaques were isolated, plaque pu-
rified once more, and used to infect the hprt2 HeLa cell
ine D980R (Kerr and Smith, 1991) in the presence of 1
mg/ml 6-thioguanine (6-TG) (Isaacs et al., 1990). This
selected against Ecogpt expression and produced both
a wild-type virus (vWTB7R) and a deletion B7R virus
(vDB7R).
The revertant virus was constructed using TDS as
described above. CV-1 cells were infected with vDB7R at
0.05 PFU/cell and transfected with pNP5 DNA. The MPA-
resistant intermediate plaque was grown on D980R cells
with 6-TG to form a revertant virus (vB7R-rev) in which the
B7R locus had been restored to that of wild-type virus.
Production and purification of polyclonal antisera
Two polyclonal rabbit antisera to the B7R protein were
produced. The first, called a-B7R-1 Ig, was raised
against B7R amino acids 20–182 (lacking the hydropho-
bic N terminus) expressed from plasmid pNP1 in E. coli
strain TG1 as a GST-B7R fusion protein (Smith and John-
son, 1988), and the antiserum produced was affinity pu-
rified. New Zealand white rabbits were immunised sub-
cutaneously with ;375 mg of the GST-B7R fusion protein
in complete Freund’s adjuvant, followed by similar injec-
tions in incomplete Freund’s adjuvant at 3- and then
6-week intervals. Serum samples were collected 10–14
days after each boost. The immunoglobulin (Ig) fraction
of anti-B7R serum was purified over a protein-A–Sepha-
rose column (Sigma) and eluted at pH 3 (Harlow and
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76 PRICE ET AL.Lane, 1988). This fraction was then affinity purified fur-
ther. First, the Ig was passed through a column of GST
coupled to glutathione–agarose (Smith and Johnson,
1988). After addition of the Ig fraction to this column, the
resulting flow-through was collected and applied to a
GST-B7R-glutathione-agarose column. Bound Ig was
eluted at pH 3 to produce a-B7R-1 Ig.
The second antibody was called a-B7R-2 and was
aised against synthetic peptide SNTYYSKYDF (B7R
mino acids 173–182) coupled to keyhole limpet hemo-
yanin by subcutaneous injection of 500 mg of antigen in
omplete Freund’s adjuvant. This same amount of anti-
en, in incomplete Freund’s adjuvant, was used in
ooster doses at 2- and then 4-week intervals. Serum
amples were taken 10–14 days after each boost. Prior to
he use of this antibody in immunofluorescence, the
ntiserum was adsorbed against BS-C-1 cells that were
nfected at 5PFU/cell with vDB7R for 12 h.
orthern blot analysis
RNA was extracted from RK13 cells that had been
ock-infected or infected with VV WR at 10 PFU/cell in
he presence or absence of 100 mg/ml cycloheximide
(Cyclo) or 40 mg/ml cytosine b-D-arabinofuranoside
araC) and prepared according to established protocols
Ausubel et al., 1990). Samples of the RNA (5 mg) were
denatured in 0.53 MOPS buffer containing 50%
deionised formamide and 6.5% formaldehyde at 65°C for
10 min. After electrophoresis through a 1.2% agarose gel
and transfer to a nylon Hybond N1 membrane (Parkin-
son and Smith, 1994), the membrane was hybridised with
a 32P-labeled, ssRNA probe. The anti-sense (complemen-
tary) ssRNA probe was produced from the HindIII-lin-
earised vector pNP3 by the use of an in vitro transcription
kit (Promega Riboprobe) in the presence of SP6 RNA
polymerase.
Immunoblotting
Cells were infected with vWTB7R at 10 PFU/cell or
mock-infected for 1 h and then incubated in the presence
or absence of 40 mg/ml araC, 10 mg/ml tunicamycin, or 1
mM monensin for 24 h in DMEM with 2.5% FBS. Extracts
of infected cells were prepared and analysed by immu-
noblotting as described (Parkinson and Smith, 1994).
Blots were incubated with rabbit a-B7R-1 Ig (diluted
:100) in PBST-5% overnight at 4°C. The rabbit polyclonal
ntisera against VV proteins B5R (Engelstad et al., 1992)
r B1R (Banham and Smith, 1992) or the murine MAb
B1.1 against VV protein D8L (Parkinson and Smith, 1994)
ere diluted at 1:2500 in PBST-5%, and membranes were
ncubated with these antibodies for 1.5 h at RT where
ndicated. Following washes in PBST, bound Ig was de-
ected by incubation with a 1:2000 dilution of a horse-
L
Tadish peroxidase (HRP)-conjugated goat a-rabbit or
a-mouse Ig (Sigma) in PBST-5% for 1 h at RT. After
washing in PBST, immune complexes were detected
using the enhanced chemiluminescence (ECL) detection
system (Amersham) according to the manufacturer’s pro-
tocol.
For analysis of virion proteins, 25 mg of IMV or EEV
purified as described above), or extracts from vWTB7R-
nfected cells harvested at 24 h p.i., were resolved by
DS–PAGE, transferred to nitrocellulose membranes and
mmunoblotted as above.
To analyse proteins in the supernatant of infected
ells, BS-C-1 cell monolayers were mock-infected or
nfected with vWTB7R, vDB7R, or vB7R-rev at 2 PFU/cell.
fter 1 h, the unbound virus was removed and the cells
ere washed with PBS and incubated in DMEM. Cellular
nd supernatant fractions were harvested at 24 h p.i. The
upernatant was centrifuged at low speed (800 g, 4°C, 5
in in a Beckman GPR centrifuge, GH 3.7 rotor) to
emove detached cells and then at high speed (17,500 g,
°C, 2 h in a Beckman L8-M ultracentrifuge, SW 41 rotor)
o remove EEV particles. Proteins in the clarified super-
atant were precipitated by 10% trichloroacetic acid
TCA), redissolved in protein loading buffer, analysed by
DS–PAGE alongside extracts from infected cells, trans-
erred to nitrocellulose membranes, and immunoblotted
s above.
mmunofluorescence
BS-C-1 cells were grown on glass coverslips and
ere infected with vWTB7R or vDB7R at 2 PFU/cell. At
2 h p.i. the cells were washed three times in ice-cold
BS and then were fixed at 4°C with freshly prepared
% (w/v) and then 8% PFA in 250 mM HEPES, pH 7.4 for
0 and 50 min, respectively. The cells were washed in
BS, blocked with 50 mM ammonium chloride for 10
in at RT, and permeabilised with 0.2% Triton X-100 in
BS for 5 min at RT. The cells were washed three
imes with 10% FBS/PBS and blocked with this solution
or 1 h at RT. For double labeling, the rabbit polyclonal
a-B7R-2 antibody and mouse MAb 1D3 against PDI
Vaux et al., 1990) were diluted (1:100 or 1:50, respec-
tively) in 10% FBS/PBS and added to cells for 45 min at
RT. Cells were rinsed again with 10% FBS/PBS prior to
incubation for 30 min at RT with rhodamine-conjugated
goat a-rabbit IgG or FITC-conjugated goat a-mouse
gG (both Sigma) at a 1:200 dilution in 10% FBS/PBS.
he cells were rinsed three times in PBS and once
ith H2O, and the coverslips were mounted in Mowiol
Hoechst). Samples were analysed using a Bio-Rad
CR 1024 laser scanning confocal microscope and
mages were collected either with COMOS-7 or with
asersharp-4 and processed with Adobe Photoshop
M software.
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77VV GENE B7R ENCODES PROTEIN THAT AFFECTS VIRUS VIRULENCEPre-embedding immunocytochemistry
BS-C-1 cells were grown on glass coverslips and in-
fected with vWTB7R or vDB7R at 5 PFU/cell. At 18 h p.i.
the cells were washed three times in ice-cold PBS and
fixed at 4°C with freshly prepared 4% (w/v) and then 8%
PFA in 250 mM HEPES, pH 7.4, for 10 and 50 min,
respectively. The cells were washed in PBS, blocked with
50 mM ammonium chloride for 10 min at RT and then
permeabilised with 0.1% saponin in 10% FBS/PBS for 30
min at RT. The a-B7R-2 antibody was diluted 1:100 in 0.1%
aponin/10% FBS/PBS and added to the cells for 2 h at
T. Cells were rinsed three times with 0.1% saponin/10%
BS/PBS prior to incubation with a HRP-conjugated goat
a-rabbit Ig (Sigma) at a dilution of 1:50 in 0.1% saponin/
10% FBS/PBS for 2 h at RT. The cells were left overnight
at 4°C prior to incubation in diaminobenzidine (DAB) for
2 min, and in DAB/H2O2/200 mM sodium cacodylate pH
7.4 for 30 min. The reaction was stopped with 200 mM
sodium cacodylate pH 7.4, and the sample was postfixed
in 1% osmium tetroxide/1.5% potassium ferrocyanide for
60 min at RT. After being washed in water and then
incubated in 0.5% magnesium uranyl acetate overnight at
4°C, the cells were washed again in water and then
dehydrated in ethanol and flat embedded in Epon. Sec-
tions of 80–150 nm were cut parallel to the surface of the
coverslip and stained for 30 s in lead citrate as a contrast
agent. Sections were examined in a Zeiss Omega EM
912 electron microscope (LEO Electron Microscope Ltd.),
equipped with a Proscan cooled, CCD camera (1024 3
1024 pixels). Digital images were captured with the inte-
grated Soft Imaging Software (SIS) image package (SIS
Imaging Software, GmbH, Munster, Germany) and were
processed using Adobe Photoshop TM software.
In vitro transcription and translation
For in vitro transcription, the designated gene was
cloned into the pGEM-3Z or pGEM-4Z vector (Promega)
under control of the T7 promoter. Plasmid pNP3 contains
the B7R gene in pGEM-4Z, and the VV A38L gene was
cloned into pGEM3Z (Parkinson et al., 1995). These plas-
mids were linearised downstream of the coding region
by digestion with restriction endonucleases EcoRI and
HindIII, respectively, and transcription and translation
reactions were performed using Promega riboprobe and
reticulocyte lysate kits (as directed by the manufacturer).
Canine pancreatic microsomes were also obtained from
Promega.
The B7R mRNA was translated in vitro in the pres-
ence or absence of microsomes for 2 h at 30°C, and
then soluble or membrane components were sepa-
rated by centrifugation at 13,000 g at 4°C for 45 min.
The membrane sample was dissolved in reticulocyte
lysate buffer, and all samples were then lysed in pro-
tein loading buffer (Laemmli, 1970), boiled at 100°C for s5 min, and resolved by SDS–PAGE (all gels were 15%
polyacrylamide).
To determine whether proteins were co- or posttrans-
lationally associated with microsomes, in vitro transla-
tion was performed in the presence or absence of mi-
crosomes for 1 h, and then microsomes were added to
the sample hitherto lacking microsomes, in the presence
of 100 mg/ml cycloheximide. The incubation was contin-
ued for 1 h at 30°C, after which labeled B7R protein was
immunoprecipitated using 10 ml of a-B7R-2 antibody as
described below. Samples were then analysed by SDS–
PAGE.
Immunoprecipitation
B7R protein synthesised in vitro. Following in vitro
translation in the presence or absence of membranes,
samples were mixed with 1 ml of RIPA buffer (150 mM
NaCl, 0.5% sodium deoxycholate, 1% NP40, 1% SDS, and
50 mM Tris–HCl, pH 7.5), vortexed, and incubated on ice
for 10 min prior to homogenisation in a 1-ml syringe with
a 26-gauge needle. Insoluble material was removed by
centrifugation at 13,000 g for 10 min, and the soluble
fraction was then added to a further 4 ml of RIPA buffer
together with 10 ml of a-B7R-2 antibody for 12 h at 4°C.
lternatively, B7R protein was translated in vitro in the
resence of microsomes and the reaction mix was incu-
ated in the presence or absence of 0.1% Triton X-100 in
5 mM CaCl2 and 50 mM Tris–HCl, pH 8. Immunopre-
cipitation was performed using the a-B7R-2 antibody or
no antibody in the 25 mM CaCl2, 50 mM Tris–HCl, pH 8,
for 12 h at 4°C. For all immunoprecipitations 7 mg of
protein-A–Sepharose beads were added for 3 h at 4°C.
The samples were washed 3 times in RIPA buffer or in 25
mM CaCl2 and 50 mM Tris–HCl, pH 8 (as appropriate),
resuspended in protein loading buffer, boiled at 100°C
for 5 min and resolved by SDS–PAGE.
B7R protein synthesised in infected cells. TK2143B
cells were infected with vWTB7R at 10 PFU/cell for 1 h.
Unbound virus was removed and the cells were incu-
bated in DMEM with 2.5% FBS. At 8 h p.i. the cells
were starved for 30 min in medium lacking methionine
and cysteine and then radio-labeled with 50 mCi of
romix ([35S]met and [35S]cys) (Amersham) and 50 mCi
of L-[35S]cysteine (NEN Life Science Products) for 1 h.
ells were washed three times in PBS and harvested
n 1 ml of RIPA buffer. Samples were then mixed,
omogenised, and centrifuged as for proteins synthe-
ised in vitro (see above). Each soluble fraction was
incubated with 10 ml of preimmune rabbit serum for 3 h
at 4°C, followed by protein-A–sepharose for 3 h at
4°C, and immune complexes were removed by cen-
trifugation. The B7R protein was then immunoprecipi-
tated with a-B7R-2 antibody followed by protein-A–
epharose as described above.
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78 PRICE ET AL.Extraction of proteins with Na2CO3 or Triton X-100
After in vitro translation of yeast a-factor, or VV pro-
teins B7R or A38L in the presence of microsomes, mem-
branes and soluble fractions were separated by centrif-
ugation at 13,000 g at 4°C for 45 min. The membrane
ellet was resuspended in PBS, divided into two, and
ne half was treated with 0.1 M Na2CO3, pH 11, and the
ther half treated with 0.1% Triton X-100 each for 30 min
t 4°C. The reaction mixture was then floated over a 10%
w/v) sucrose cushion and centrifuged at 13,000 g, 4°C,
5 min to separate the soluble and insoluble fractions.
reatment of microsomes with trypsin
Yeast a-factor and VV B7R protein were translated in
the presence of microsomes in vitro, and each sample
as divided into three parts. One was incubated without
ither trypsin or Triton X-100, the second was incubated
ith both 0.1 mg/ml trypsin and 0.1% Triton X-100, and the
hird was incubated with 0.1% Triton X-100 and 0.1 mg/ml
rypsin that had been inactivated by pretreatment with 1
g/ml trypsin inhibitor (Sigma). Incubations were contin-
ed for 45 min at 37°C. Parallel translation reactions, in
he presence of microsomal membranes, were sepa-
ated into soluble and pellet fractions by centrifugation at
3,000 g, 4°C for 45 min. The membrane pellet was
divided into three equal parts, one of which was incu-
bated without either trypsin or Triton X-100, the second
was incubated with 0.1 mg/ml trypsin but not Triton
X-100, and a third was incubated with both 0.1 mg/ml
trypsin and 0.1% Triton X-100.
Virus growth curves
BS-C-1 cells were infected at 0.01 PFU/cell in DMEM
with 2.5% FBS for 1 h, washed with PBS to remove
unbound virus and then incubated in DMEM with 2.5%
FBS. At various times postinfection, the culture superna-
tant was removed and centrifuged at 800 g at 4°C for 5
min to pellet-detached cells, and the supernatant re-
tained as the EEV fraction. Cells were washed with PBS,
scraped into DMEM with 2.5% FBS, added to the pelleted
cells from above, freeze-thawed three times, and soni-
cated for 15 s to produce the cell-associated virus sam-
ple. Virus titers were determined by plaque assay on
BS-C-1 cells.
Virulence assays in mice
Groups of 5 BALB/c mice were inoculated intranasally
under general anaesthesia with either 104, 105, or 106
PFU of vWTB7R, vDB7R, or vB7R-rev in 25 ml PBS. Mice
were weighed daily before and after infection, and the
mean weights for each group of animals were calculated
and compared with the mean weight of the same group
of animals on day 0. Animals that had lost 30% of their
body weight were killed by cervical dislocation.Female BALB/c mice, 8 weeks old, were anaesthe-
tised and injected intradermally in the left ear pinnae
with 5 3 104 PFU of virus diluted in 10 ml of PBS. The
iameter of lesions produced on infected ears was es-
imated daily to the nearest 0.5 mm using a micrometer.
he titer of infectious virus in ears at various times after
noculation was determined as described (Tscharke and
mith, 1999). Aliquots of the diluted viruses that were
sed for infection of mice were titrated on BS-C-1 cells to
onfirm the dose administered.
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